Unaudited Financial Results dated August 13, 2025, as per the attached annexure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kothari Fermentation & Biochem reported its unaudited Q1 FY26 results on August 13, 2025. Revenue from operations fell to Rs. 2,375.31 lakhs from Rs. 2,635.52 lakhs in Q1 FY25, a year-on-year decline of roughly 9.9%. The company swung to a net loss of Rs. 112.46 lakhs versus a profit of Rs. 109.78 lakhs a year earlier, with basic EPS turning negative at (Rs. 0.75) compared to Rs. 0.73. Total expenses held nearly flat, but a lower top line combined with steady depreciation and finance costs pushed pre-tax profit from Rs. 95.92 lakhs to a loss of Rs. 88.70 lakhs. The statutory auditor issued an unmodified limited review but flagged an Emphasis of Matter on PF dues of Rs. 9.59 lakhs outstanding for over six months. Separately, the board approved the re-appointment of Mr. Siddhant Kothari as whole-time director, the appointment of Mr. Varun Kumar as an independent director, and accepted the resignation of Dr. Rajiv Agarwal.
The quarter is weak on both counts — shrinking revenue and a swing back to losses — which is likely to weigh on near-term sentiment. The auditor's emphasis on overdue statutory dues, while not modifying the opinion, is a governance concern investors should monitor closely.